Maintaining remission in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis who have kept their autoantibodies in check after at least 2 years on rituximab therapy has ...
The authors reviewed the literature to identify high-quality studies (observational and controlled) of ANCA-associated vasculitis that included a predetermined target dose of steroids at the end of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback